In the Bio-Pharmaceutical Sciences master’s programme you are trained at the leading edge of drug-design and fundamental research of new drugs, optimization of existing drugs, and personalised medicine.
Despite major advances in drug-research, many common diseases such as cancers, neurological diseases, cardiovascular disease and other auto-immune diseases, lack effective treatment, or are found incurable. You are trained for a scientific career in drug research and development. Depending on your interest, you can choose from seven specialisations to further extend your scientific training and theoretical background.
Read more about our Bio-Pharmaceutical Sciences programme.
Find more reasons to study Bio-Pharmaceutical Sciences at Leiden University.
The master’s programme of Bio-Pharmaceutical Sciences (BPS) aims to train you in the research area of bio-pharmaceutical sciences and drug research in such a way that you have extensive knowledge and hands-on experience to be able to work independently as a scientific researcher. Moreover, you have a wide range of other career opportunities bio-pharmaceutical industry, science communication, and education.
Developed in partnership with the pharmaceutical industry, the four pathways of our MSc in Pharmaceutical Industrial Advanced Training (PIAT) are postgraduate-level training programmes designed for scientists and managers working in the pharmaceutical industry and NHS in the fields of product development, manufacturing and quality assurance.
Many of our units have been developed to support those seeking to build their QP portfolio and our team includes QPs who are willing to support your development through this pathway.
You can also take individual units as standalone CPD courses. Please contact us for further details of the units that can be taken.
We offer a three-day summer school each year to allow you to meet fellow students and your tutors while attending workshops to support your learning and development in the units.
For our Business Development and Licensing pathway, we offer a two-day winter school held in London that covers the units within this key course for business development executives.
Below are some links that may be useful if you're thinking about studying PIAT.
Example dissertation titles
Below are examples of previous dissertations undertaken on the PIAT course.
All units commence in April and October. You can see a list of units in the table below, or view units specific to each of the four pathways:
Our alumni have used the learning and opportunities gained from this course to advance their careers in a range of roles and areas.
Some have moved to management positions, while others have taken on roles with more responsibility, becoming team leaders, heads of projects or responsible for new and larger areas, regions or territories.
As part of the course, our students build networks of contacts and join a growing community of leaders within the industry.
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.
You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.
The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.
Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.
Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.
For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.
You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.
The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.
Extensive practical experience
You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.
Meet the course team
Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.
Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.
Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.
Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.
He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.
Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.
Taught course units will predominantly use lectures and workshops.
For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.
The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.
You will be assessed through oral presentations, single best answer exams, written reports and dissertation.
For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.
Publication-based/dissertation by publication
Service development/professional report/ report based dissertation
Adapted systematic review (qualitative data)
Full systematic review that includes data collection (quantitative data)
Qualitative or quantitative empirical research
Qualitative secondary data analysis/analysis of existing quantitative data
Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review
Teaching will take place within The Christie NHS Foundation Trust , Withington.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: [email protected]
This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.
The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.
The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.
The pharmaceutical industry and pharmacies are developed in a complex and highly regulated environment. Research of new drugs is quite expensive and you need enough time for it.
For that reason, pharmaceutical marketing professionals must be prepared to meet the challenges they encounter on the way to the success of the brands they manage.
This Master MBA with specialization in Pharmaceutical Marketing offers the opportunity to train and develop the skills in the field of business management, marketing, branding and digital communication in order to implement strategic plans to products, services or companies with the best strategy adapted to all current regulations.
This master aimed at the pharmaceutical industry claims that the student is able to implement a strategy to address successfully as well as enable you so you can evaluate the suitability of a business strategy, analyzing the marketing plan in which it is based, thus ensuring the desired results for your company.
MFI offers a flexible methodology adapted to your needs, whatever your geographical location or time availability. This master can be studied under:
All contents are fully updated and have great technical, easily understandable and with a clear practical vocation rigor. IMF offers you:
Continuous assessment as advances in the study of the Master. Each module will be assessed by combining online and development of case examination; overcoming will free each subject.
Likewise, obtaining master's degrees and Master MFI University Camilo José Cela, subject to overcoming each module testing and the development of a master work order.
Students who pass this master can work in:
This Clinical Pharmacology degree programme offers focused training which integrates basic and clinical sciences, and equips students with the essential skills required to function effectively as a clinical pharmacologist in the 21st century. As a student on the MSc Clinical Pharmacology programme, you will acquire core skills, enabling an appreciation of how to apply clinical pharmacological, regulatory and ethical principles to the optimisation of therapeutic practice and clinical research. Crucially, in addition to a firm grasp of the principles of molecular pharmacology, you will also gain foundational knowledge in the emerging science of pharmacogenomics and personalised medicine.
You will attend lectures, seminars and tutorials and take part in lab, project and team work.
In addition you will undertake a dissertation/project.
Career opportunities include positions in academia, health care and the pharmaceutical industry; returning to more advanced positions within a previous clinical environment (eg pharmacicts, clinicians); and PhD study.
The Clinical Pharmacology course will give you the advanced skills and knowledge to evaluate the safety of new medicinal products in preparation for medical approval. It is one of three modular programmes in Pharmaceutical Medicine designed for working physicians, clinical scientists and allied health professionals interested in the clinical development process.
Clinical Pharmacology is the study of how drugs influence human physiology and the way the body responds. This study forms a vital part of the clinical development of new medicines and requires an advanced understanding of pre-clinical science, as well as the ethical and legal requirements for specialist research programmes. A well-designed clinical pharmacology programme informs the final regulatory of a new medicine. Therefore, generating skilled clinical pharmacologists is critical for the efficiency of future drug development.
This course will provide you with a broad knowledge and understanding of the drug development process and the medical aspects of the marketing of pharmaceutical products. You will also have opportunities to undertake advanced research projects and the possibility of one or more thesis publications.
The study programme is made up of optional and required modules. The MSc pathway requires modules totalling 180 credits to complete the programme, including 60 credits from a dissertation of around 15,000 - 18,000 words. The Postgraduate Diploma pathway will require modules totalling 120 credits, while the Postgraduate Certificate will require you to study modules totalling of 60 credits to complete the course.
If you are studying full-time, you will complete the course in one year, from September to September. If you are studying for the MSc qualification part-time, your programme will take up to four years to complete. The Postgraduate Diploma and Certificate pathways are both part-time courses. The Postgraduate Diploma will take two to three years to complete and the Postgraduate Certificate up to two years.
This course is for those working in or seeking to work in the field of clinical drug development. It covers all aspects of the clinical development process through from the earliest studies to post marketing activities. It will enhance knowledge and skills in all aspects of clinical research, drug regulation and drug safety.
The primary method of assessment for this course is a combination of coursework and written examinations. The MSc study programme also requires a research and dissertation on the subject of clinical pharmacology.
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they are subject to change.
Our Master of Research (MRes) in Translational Medicine will give you the research skills you need to use state-of-the-art biotechnologies to rapidly translate disease research into improved clinical healthcare.
Our understanding of the molecular basis of disease and drug mechanisms has improved dramatically in recent years, yet there is a distinct shortage of individuals able to apply this knowledge into effective clinical benefit. The core aim is to train the next generation of scientists able to 'fast-track' biological and scientific data into advanced therapies and diagnostics tools.
With advances in technology, graduates are faced with heightened expectations to conduct effective bioscience research. Employers demand skillsets with biological, medical, physical and computational characteristics, and our course is designed to provide this breadth of training.
You will learn omics skills and techniques such as genetics, genomics, transcriptomics, proteomics and metabolomics. Our training in metabolomic techniques is novel for a UK course, while our teaching on the integration of different omic platforms and data in a systems medicine strategy is also unique.
The MRes course consists of four taught units - which together make up the PGCert - plus an extended 35-week project that can be undertaken at the University, the Manchester Cancer Research Centre or a teaching hospital in Greater Manchester.
You can choose from a range of projects covering areas such as the use of gene expression profiling, proteomics, metabolomics, stem cell research, tissue culture or pharmacogenetics in the biology of cancer, cardiovascular disease, infectious diseases, stroke or diabetes.
Completing our course will open up a route into PhD research. You may also pursue a career in academia or the pharmaceutical or biotechnology industries, or as a clinical academic.
Extensive research experience
The 35-week research project for the MRes award offers the chance to conduct ambitious projects in areas such as cancer, cardiovascular disease, inflammation, mental health, infectious diseases, stroke or diabetes, using methods such as stem cell research, proteomics, metabolomics, tissue culture or pharmacogenetics.
Integrated focus on key topics
Our course has a strong and integrated focus on genetics, genomics, proteomics and metabolomics biotechnology and data interpretation, which are strengths within Manchester and are identified as core areas of bioscience growth.
Teaching comprises four taught units delivered using a variety of face-to-face, workshop and e-learning approaches and an extended 35-week research project for the MRes award.
Examples of research projects include the following.
Find out more by visiting the postgraduate teaching and learning page.
More than 50% of our graduates progress into PhD research at Manchester or other universities such as Cambridge, Imperial College London, Newcastle, Glasgow, Liverpool and Bristol.
Around 15% pursue a career in the pharmaceutical or biotechnology industry in the UK or abroad.
Approximately 25% are intercalating medics who complete their medical education. An estimated 10% pursue an undergraduate medical degree.
The purpose of the Master of Science in Pharmaceutical Biotechnologies (two years, 120 CFU) is to endow students with a sound scientific knowledge for modern pharmaceutical research and health biotechnologies.
The organization and the needs of the research in the pharmaceutical field have changed dramatically in recent years. Modern research in both academic and industrial setting is intensely devoted to the study and development of biopharmaceuticals, including the development of biologics and monoclonal antibodies of new conception. Currently, the pharmaceutical scientist requires a thorough education and expertise in molecular biology, genetics, recombinant DNA techniques and bioinformatics, with a solid background in chemistry, pharmacology and advanced pharmaceutical technology. The professionals working in pharmaceutical R&D and production must possess a sound interdisciplinary knowledge, including the specific technical and regulatory issues dedicated to the research, development and monitoring of innovative drugs and biosimilars.
The Master of Science focuses on transferring knowledge, endowing students with strong technical skills (hard skills) and interpersonal skills (soft skills), building at the same time those competencies needed to face the changing pharmaceutical marketplace. Graduates in Pharmaceutical Biotechnologies will acquire a solid knowledge in biochemistry, molecular biology and protein engineering, immunology, pharmacology and pharmaceutical technology, and in those disciplines required to design, analyze and formulate innovative drugs such as biologics and drugs employed in targeted therapies. The knowledge of the physico-chemical properties of molecules and macromolecules enable students to apply the analytical methods required for the identification, purification and characterization of biopharmaceuticals during production and quality control.
Strengths: innovative teaching approach; critical approach to science (not only theory!); students have an active role in organizing events, projects and investigations; excellent Teacher/Students ratio; high student satisfaction score (>8.5/10); high employability rate (90%, in Italy); most students graduate with full marks and pursue a PhD abroad.
Graduates in Pharmaceutical Biotechnologies will operate in various areas of academic and industrial research at national and international level. They will be able to tackle problems related to the study and development of drugs and diagnostics and will work in several fields associated with the production and quality control of the pharmaceutical, biopharmaceutical, diagnostic and scientific instrumentation, as well as the cosmetic and nutraceutical industries and those interested in human and animal nutrition.
The University of Padova, the Veneto Region and other organisations offer various scholarship schemes to support students. Below is a list of the funding opportunities that are most often used by international students in Padova.
You can find more information below and on our website here: http://www.unipd.it/en/studying-padova/funding-and-fees/scholarships
You can find more information on fee waivers here: http://www.unipd.it/en/fee-waivers
Our MSc in Pharmaceutical Technology and Quality Assurance is aimed at pharmacy, health and biomedical professionals working in the technical services for the NHS or private sector organisations who want to update their skills and knowledge while gaining an academic qualification.
This three-year part-time course allows you to choose from a range of optional units to enable you to develop in your chosen field of interest. Some units allow you to learn alongside students from other healthcare disciplines.
Some of the topics covered by the course are radiopharmacy, aseptics, formulation sciences, production and clinical trials.
You will learn from experts from the NHS and industry, who deliver lectures and workshops as part of the course.
You will also be able to apply what you learn in practical workshops and visits to and placements in NHS and industrial environments.
We aim to provide you with an understanding of core principles and features of clinical pharmaceutical science and professional training.
Successful completion of the course will enable you to:
Students who complete the full MSc qualification will achieve the objectives for the PGDip, and will also critically and creatively evaluate current issues in practice and conduct research that advances pharmaceutical technology, quality assurance and decision-making related to patient care.
This is a residential and distance learning course. Units will include a taught component delivered in Manchester that is supported by extensive experience achieved in the workplace and on visits to specialist facilities.
We use a blend of online and face-to-face methods. This will include small group tutorials, workshops and experience-based learning. You will have a nominated tutor at the University and your practice base to provide guidance on work-based activities and written assignments.
You will engage in work-based learning and demonstrate this to the academic team by producing portfolios of evidence detailing your experiences gained during each visit or placement.
Each unit has a designated leader who is responsible for individual assessments, under the guidance of the course director. All assessments will be monitored and reviewed by the Exam Board.
You must satisfy the course requirements in Year 1 before you can proceed to Year 2 of the course. The timing of re-sits for written examinations will be decided by the course director on an individual basis.
You will take course units covering a wide range of topics within:
Introduction to Clinical Pharmaceutical Science 2 (30 credits)
Introduction to Clinical Pharmaceutical Science 3 (30 credits)
You will complete course units from a selection covering:
Optional Components (choose 2)
You will complete your research dissertation.
There is flexibility through the range of optional units to allow you to develop in your chosen specialist field. Some units also provide the opportunity to learn alongside students from other healthcare disciplines.
The teaching blocks will be held at Chancellors Conference Centre , with some practical sessions taking place on the University campus.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service
Completing this course will help you develop your chosen career path within the pharmacy profession by gaining advanced clinical knowledge, problem solving skills and a critical awareness of the role of pharmaceutical services within the workplace.